The study was designed to determine the impact of a rurally focused telemedicine program on patient outcomes.
In a study presented at the Society of Urologic Oncology 21st Annual Meeting, researchers sought to determine the impact of a rurally focused telemedicine program on patient outcomes in the urologic oncology outpatient clinic at the University of Washington Medical Center (UWMC).
In an interview with CancerNetwork®, Adam J. Gadzinski, MD, MS, urologic oncology fellow and an acting instructor of Urologic Oncology at the Urology Clinic at UWMC, discussed the findings from this study.
Transcription:
So, what we found is that overall patient satisfaction was generally the same between both in person and telemedicine visits. But, no surprises, telemedicine didn't require essentially any travel, and at the University of Washington we tend to be a referral center for the state of Alaska and some of the other Pacific Northwest states, so some of our patients were spending a tremendous amount of money just to come and see us for outpatient visit appointments. And of our in-person visits, we found that almost 10% were spending over $1000 to come and see us in person, not to have surgery, just for an office visit; and telemedicine eliminated essentially all of those travel costs.
Frontline Chemo-Free Regimen Supported in HR+/HER2+ Breast Cancer Therapy
January 1st 2024Combining anastrozole with palbociclib, trastuzumab, and pertuzumab as a frontline therapy for hormone receptor–positive, HER2-positive breast cancer may avoid some of the toxicities associated with chemotherapy, says Amy Tiersten, MD.
Oncology On-The-Go Podcast: ASCO 2023 Recap
June 19th 2023Experts from University of California, Los Angeles Health and Mayo Clinic discuss key data presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in the gynecologic and gastrointestinal cancer spaces and how they may impact patient care.